These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 16571647)

  • 1. The molecular genetics of Marfan syndrome and related disorders.
    Robinson PN; Arteaga-Solis E; Baldock C; Collod-Béroud G; Booms P; De Paepe A; Dietz HC; Guo G; Handford PA; Judge DP; Kielty CM; Loeys B; Milewicz DM; Ney A; Ramirez F; Reinhardt DP; Tiedemann K; Whiteman P; Godfrey M
    J Med Genet; 2006 Oct; 43(10):769-87. PubMed ID: 16571647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of Marfan syndrome.
    Boileau C; Jondeau G; Mizuguchi T; Matsumoto N
    Curr Opin Cardiol; 2005 May; 20(3):194-200. PubMed ID: 15861007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders.
    Mizuguchi T; Matsumoto N
    J Hum Genet; 2007; 52(1):1-12. PubMed ID: 17061023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes.
    Sakai H; Visser R; Ikegawa S; Ito E; Numabe H; Watanabe Y; Mikami H; Kondoh T; Kitoh H; Sugiyama R; Okamoto N; Ogata T; Fodde R; Mizuno S; Takamura K; Egashira M; Sasaki N; Watanabe S; Nishimaki S; Takada F; Nagai T; Okada Y; Aoka Y; Yasuda K; Iwasa M; Kogaki S; Harada N; Mizuguchi T; Matsumoto N
    Am J Med Genet A; 2006 Aug; 140(16):1719-25. PubMed ID: 16835936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing in patients with aortic aneurysms/dissections: a novel genotype/phenotype correlation?
    Waldmüller S; Müller M; Warnecke H; Rees W; Schöls W; Walterbusch G; Ennker J; Scheffold T
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):970-5. PubMed ID: 17418587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular pathogenesis of the Marfan syndrome.
    Robinson PN; Booms P
    Cell Mol Life Sci; 2001 Oct; 58(11):1698-707. PubMed ID: 11706995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marfan syndrome. Part 1: pathophysiology and diagnosis.
    Cañadas V; Vilacosta I; Bruna I; Fuster V
    Nat Rev Cardiol; 2010 May; 7(5):256-65. PubMed ID: 20351703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.
    Wang WJ; Han P; Zheng J; Hu FY; Zhu Y; Xie JS; Guo J; Zhang Z; Dong J; Zheng GY; Cao H; Liu TS; Fu Q; Sun L; Yang BB; Tian XL
    J Mol Med (Berl); 2013 Jan; 91(1):37-47. PubMed ID: 22772377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited.
    Adès LC; Sullivan K; Biggin A; Haan EA; Brett M; Holman KJ; Dixon J; Robertson S; Holmes AD; Rogers J; Bennetts B
    Am J Med Genet A; 2006 May; 140(10):1047-58. PubMed ID: 16596670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.
    Mátyás G; Arnold E; Carrel T; Baumgartner D; Boileau C; Berger W; Steinmann B
    Hum Mutat; 2006 Aug; 27(8):760-9. PubMed ID: 16791849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations.
    Teekakirikul P; Milewicz DM; Miller DT; Lacro RV; Regalado ES; Rosales AM; Ryan DP; Toler TL; Lin AE
    Am J Med Genet A; 2013 Jan; 161A(1):185-91. PubMed ID: 23239472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
    Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome.
    Zilberberg L; Phoon CK; Robertson I; Dabovic B; Ramirez F; Rifkin DB
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14012-7. PubMed ID: 26494287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders.
    Attias D; Stheneur C; Roy C; Collod-Béroud G; Detaint D; Faivre L; Delrue MA; Cohen L; Francannet C; Béroud C; Claustres M; Iserin F; Khau Van Kien P; Lacombe D; Le Merrer M; Lyonnet S; Odent S; Plauchu H; Rio M; Rossi A; Sidi D; Steg PG; Ravaud P; Boileau C; Jondeau G
    Circulation; 2009 Dec; 120(25):2541-9. PubMed ID: 19996017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental regulation by fibrillin-1.
    Sengle G; Tsutsui K; Keene DR; Tufa SF; Carlson EJ; Charbonneau NL; Ono RN; Sasaki T; Wirtz MK; Samples JR; Fessler LI; Fessler JH; Sekiguchi K; Hayflick SJ; Sakai LY
    PLoS Genet; 2012 Jan; 8(1):e1002425. PubMed ID: 22242013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of young adult patients with aortic disease not fulfilling the diagnostic criteria for Marfan syndrome.
    Akutsu K; Morisaki H; Okajima T; Yoshimuta T; Tsutsumi Y; Takeshita S; Nonogi H; Ogino H; Higashi M; Morisaki T
    Circ J; 2010 May; 74(5):990-7. PubMed ID: 20354336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillin-1 regulates the bioavailability of TGFbeta1.
    Chaudhry SS; Cain SA; Morgan A; Dallas SL; Shuttleworth CA; Kielty CM
    J Cell Biol; 2007 Jan; 176(3):355-67. PubMed ID: 17242066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
    Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
    Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.